Country/Region

Topic

December 16, 2012

The M23 rebels' advance on Goma left hundreds of casualties and hundreds of thousands of displaced people in its wake.  In addition to its activities in several large hospitals, Doctors Without Borders/Médecins Sans Frontières (MSF) has set up mobile clinics inside the camp and continues consultations at the health center.

December 12, 2012

Doctors Without Borders/Medecins Sans Frontieres (MSF), VII Photo, and UNION HZ present FATAL NEGLECT, a six-part documentary film project, that tells the stories of millions of patients left behind by the global health revolution. In Fatal Neglect: The Global Health Revolution’s Forgotten Patients, VII photographers Seamus Murphy, Venetia Dearden, Ron Haviv, and John Stanmeyer document the impact of multidrug-resistant tuberculosis, the three deadliest neglected tropical diseases—(visceral leishmaniasis (kala azar), Human African Trypanosomiasis (sleeping sickness), and Chagas—and vaccine-preventable diseases. The award-winning photojournalists traveled to Mali, Paraguay, South Sudan, and Tajikistan to capture the stories of frontline health workers trying to fight diseases that affect millions of people and kill hundreds of thousands each year yet garner little attention from drug developers, policy makers, or the mass media.

November 12, 2012

For the first time, Doctors Without Borders/Médecins Sans Frontières (MSF) is employing seasonal malaria chemoprevention (SMC) in Chad and Mali. 170,000 children aged between three months and five years received anti-malaria medicines during the peak transmission season. This treatment, recommended by the World Health Organization, will not eradicate malaria definitively. But in countries like Chad and Mali, where malaria is the first cause of infant and child mortality, it does have an important role to play in emergency situations.

October 25, 2012

In Tegucigalpa, the capital of Honduras, Doctors Without Borders/Médecins Sans Frontières (MSF) is providing medical assistance to vulnerable people facing extreme violence and a lack of access to health care. Many of these patients are young people who live on the streets and suffer the most from what MSF staff call an "epidemic of violence". Photographs and voiceover by Spencer Platt.

October 12, 2012

Doctors Without Borders/Médecins Sans Frontières (MSF) heads into Congo's tropical forest to treat the Pygmy population for yaws.

October 12, 2012

The lawsuit brought against the Indian Government by Swiss pharmaceutical company Novartis began in New Delhi on September 11. This new offensive follows the failure of a previous court case six years ago. Novartis is contesting part of Indian law on patents that enables Indian manufacturers to produce affordable generic drugs. Learn more.

October 12, 2012

Twenty-six years after first working in the country in 1986, Doctors Without Borders/Médecins Sans Frontières (MSF) teams have handed over the last remaining projects in Sri Lanka and MSF has left the country.

October 12, 2012

The pediatric unit in Niger's Guidan Roumji hospital is overwhelmed. Since the beginning of the year, MSF has treated close to 69,000 malnourished children and 175,000 cases of malaria. Southern Niger is still rife with malnutrition. In July, torrential rains destroyed crops and grain reserves. During the rainy season, malaria-transmitting mosquitoes proliferate. And malnourished children, already weak, run a higher risk of developing a severe form of malaria.

October 12, 2012

This month, we visit the Ubangi river, where MSF is treating yaws among the Pygmy population; Niger, where the rainy season and food insecurity have exacerbated malaria and malnutrition; and Sri Lanka, where after 32 years MSF is handing over its last remaining project and leaving the country. Additionally, learn about the court case Swiss pharmaceutical company Novartis has brought against India, the "pharmacy of the developing world."

September 25, 2012

On Wednesday, September 19, 200 people froze in the streets of Geneva to protest the attack on generic medicines by Swiss pharmaceutical company Novartis. To learn more, visit msfaccess.org/STOPnovartis.

Pages